|  | FCCTX subset vs. Population-based cohort | |||
---|---|---|---|---|---|
Cancer | Age groups | IRR | 95% CI lower | 95% CI Upper | P values |
Breast cancer (n = 36) | 0–29 | 0.00 | 0.00 | 23.91 | 1.0000 |
30–49 | 0.19 | 0.02 | 0.67 | 0.0002* | |
50–69 | 0.80 | 0.46 | 1.26 | 0.2639 | |
70+ | 0.56 | 0.19 | 1.27 | 0.1104 | |
Urothelial cancer (n = 33) | 0–29 | 10.10 | 0.06 | 73.70 | 0.0947 |
30–49 | 0.51 | 0.00 | 3.65 | 1.0000 | |
50–69 | 0.65 | 0.25 | 1.36 | 0.2011 | |
70+ | 1.53 | 0.83 | 2.59 | 0.0568 | |
Lung cancer (n = 25) | 0–29 | 0.00 | 0.00 | 82.68 | 1.0000 |
30–49 | 0.97 | 0.17 | 2.97 | 1.0000 | |
50–69 | 0.35 | 0.15 | 0.67 | < 0.0001* | |
70+ | 0.32 | 0.11 | 0.74 | 0.0002* | |
Pancreatic cancer (n = 13) | 0–29 | 0.00 | 0.00 | 351.13 | 1.0000 |
30–49 | 0.00 | 0.00 | 5.78 | 1.0000 | |
50–69 | 0.75 | 0.17 | 2.08 | 0.6967 | |
70+ | 1.27 | 0.42 | 2.89 | 0.4249 | |
Gastric cancer (n = 12) | 0–29 | 0.00 | 0.00 | 137.04 | 1.0000 |
30–49 | 2.94 | 0.36 | 10.51 | 0.0840 | |
50–69 | 0.38 | 0.02 | 1.73 | 0.2642 | |
70+ | 1.27 | 0.39 | 3.04 | 0.5161 | |
Eye tumours (n = 4) | 0–29 | 0.00 | 0.00 | 40.98 | 1.0000 |
30–49 | 0.00 | 0.00 | 18.10 | 1.0000 | |
50–69 | 6.19 | 1.11 | 19.07 | 0.0044* | |
70+ | 0.00 | 0.00 | 15.20 | 1.0000 |